Sanofi India Investor Relations Material
Latest events
Q1 24/25
Sanofi India
Q1 25/26
15 May, 2025
Q4 24/25
27 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sanofi India Limited
Access all reports
Sanofi India Limited is an Indian pharmaceutical company engaged in the manufacturing and marketing of prescription medicines and consumer healthcare products. It offers treatments in therapeutic areas such as diabetes, cardiovascular diseases, central nervous system disorders, and dermatology. The company is a subsidiary of global healthcare company Sanofi. It is headquartered in Mumbai, India, and its shares are listed on the BSE.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
500674
Country
🇮🇳 India